CORCEPT THERAPEUTICS INC Current Assets
CORCEPT THERAPEUTICS INC (CORT) had Current Assets of $439.68 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-29
- 2026-06-30: Assets, Current $439.68M.
- 2026-03-31: Assets, Current $426.03M.
- 2025-12-31: Assets, Current $485.46M.
- 2025-09-30: Assets, Current $541.13M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $439.68M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $426.03M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $485.46M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $541.13M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $443.11M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $438.50M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $471.60M 10-K · filed 2026-02-24 |
| 2024-09-30 | $466.98M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $560.85M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $503.37M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $458.64M 10-K · filed 2025-02-26 |
| 2023-09-30 | $431.53M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $432.59M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $533.89M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $499.25M 10-K · filed 2024-02-15 |
| 2022-09-30 | $452.40M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $419.05M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $388.22M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $266.46M 10-K · filed 2023-02-28 |
| 2021-09-30 | $401.90M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $411.27M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $409.62M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $478.50M 10-K · filed 2022-02-15 |
| 2020-09-30 | $463.49M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $438.33M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $344.78M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $307.36M 10-K · filed 2021-02-23 |
| 2019-09-30 | $267.31M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $232.66M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $216.86M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $236.82M 10-K · filed 2020-02-24 |
| 2018-09-30 | $224.19M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $197.18M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $150.82M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $124.19M 10-K · filed 2019-02-26 |
| 2017-09-30 | $93.94M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $81.28M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $66.67M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $65.69M 10-K · filed 2018-02-28 |
| 2016-09-30 | $59.78M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $54.78M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $50.51M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $48.98M 10-K · filed 2017-03-06 |
| 2015-09-30 | $45.18M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $44.69M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $44.19M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $30.23M 10-K · filed 2016-03-10 |
| 2014-09-30 | $32.38M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $39.44M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $48.12M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $58.31M 10-K · filed 2015-03-13 |
| 2013-09-30 | $66.22M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $74.57M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $84.20M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $95.06M 10-K · filed 2014-03-14 |
| 2012-09-30 | $104.62M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $38.30M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $42.78M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $39.77M 10-K · filed 2013-03-15 |
| 2011-09-30 | $46.34M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $52.69M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $25.00M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |